
Overview
Medicofarma Biotech is a company listed on NewConnect that focuses on the development of innovative drugs, medical devices, and biotechnology products aimed at preventing and treating lifestyle diseases. It offers research and development services and routine analyses for the pharmaceutical, cosmetic, food, and chemical sectors through its contract laboratory. The company is also involved in projects related to cancer therapies and the creation of plant-based medicinal products.
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Opis w nocie nr 8 w informacji dodatkowej.
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 73 days for 2024). All were audited by a statutory auditor.
- 202514/07/2026
- 202426/09/2025
- 202301/08/2024
- 202203/07/2023
- 202115/07/2022
- 202013/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 0.36
- High
- PLN 0.36
- Low
- PLN 0.32
- Volume
- 15.24K
- Avg. vol.
- 12.41K
- Market cap
- PLN 24.06M
- P/E ratio
- –
- EPS
- -PLN 0.03
- Shares outstanding
- 67.98M
- 52-week
- PLN 0.32 – 0.39
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLINBOK00010
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 9.18k | USD -162.34k | USD -162.34k |
| Q1 2026 | USD 9.72k | USD -154.78k | USD -155.05k |
| Q4 2025 | USD 2.01k | USD 127.83k | USD -28.88k |
| Q3 2025 | USD 28.13k | USD -184.58k | USD -184.58k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Medicofarma Biotech opens new laboratory in Poznań

Inwestycje.pl: Medicofarma Biotech opens R&D Centre in Poznań

Bankier.pl: Medicofarma Biotech wants to move to the GPW main market

Biotechnologia.pl: Medicofarma Biotech reveals development plans for the coming years
Forsal.pl: Biotech's plans to enter the GPW main market

Stockwatch.pl: Medicofarma Biotech's goal: systematic growth of company value
Industry
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2001-06-01.
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $130.5K$130,492 |
Buildings and premises | $1.1M$1,127,261 |
Public aid
9 public aid cases recorded, with a total value of $866,075.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $845$845 | PGE Obrót S.A. | |
| Sep 20, 2023 | Aid for research and development projects: experimental development | $579.1K$579,139 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 20, 2023 | Aid for research and development projects: industrial research | $276.3K$276,291 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Consumer credit intermediary | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pikralida sp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| Nanogroup S.A. | $843,099.47 | nanogroup.eu | ||
| Bioresearch Group sp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Warmil Tech sp. z o.o. | $434,984.59 | warmil.pl | ||
| Ergtech sp. z o.o. | $384,523.80 | ergtech.eu | ||
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl | ||
| TCI sp. z o.o. | $218,471.87 | tci.pl | ||
| Cofactor sp. z o.o. | $136,474.66 | cofactor.pl | ||
| Medesto sp. z o.o. | $120,911.45 | medesto.com.pl | ||
| Microblic sp. z o.o. | $122,383.50 | microblic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-09-16 | Address change (Ul. Walentego Roździeńskiego 11, 41-308, Dąbrowa Górnicza → Ul. Sokołowska 9/U19, 01-142, Warszawa) | |
| 2021-06-25 | Share capital increase (679,783.00 PLN → 6,797,830.00 PLN) | |
| 2021-03-15 | PKD change (Removed: 6 codes; Added: 10 codes) | |
| 2021-02-01 | Name change ("inbook" → Medicofarma Biotech) | |
| 2017-07-12 | Address change (Osiedle Robotnicze 6, 42-520, Dąbrowa Górnicza → Ul. Walentego Roździeńskiego 11, 41-308, Dąbrowa Górnicza) |
FAQ
Last updated: 2026-10-03
